Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

More On SKP.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

SkyePharma plc (SKP.L)

-LSE
220.66 Up 11.66(5.58%) Apr 17, 10:51AM EDT
Get the big picture on all your investments.
Prev Close:209.00
Open:213.75
Bid:222.75
Ask:223.25
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:210.00 - 226.65
52wk Range:37.74 - 239.75
Volume:5,259,496
Avg Vol (3m):177,387
Market Cap:101.53M
P/E (ttm):12,980.00
EPS (ttm):0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):0.12
P/S (ttm):153.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :14.55
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC, a drug delivery company, develops, manufactures, and sells oral and inhalation pharmaceutical products. Its marketed products include flutiform and ZYFLO CR for treating asthma; Relvar Ellipta/Breo Ellipta for asthma and COPD; Anor... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback